Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125568551 | 12556855 | 1 | I | 2008 | 20160418 | 20160714 | 20160714 | PER | US-SA-2016SA078735 | AVENTIS | 0.00 | F | Y | 0.00000 | 20160714 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125568551 | 12556855 | 1 | PS | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | Unknown | U | UNK | 20496 | 10 | MG | QD | ||||||
| 125568551 | 12556855 | 2 | SS | GLIPIZIDE. | GLIPIZIDE | 1 | Unknown | U | UNK | 0 | 10 | MG | QD | ||||||
| 125568551 | 12556855 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | 1 | DF | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125568551 | 12556855 | 1 | Type 2 diabetes mellitus |
| 125568551 | 12556855 | 2 | Type 2 diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125568551 | 12556855 | Blood glucose increased | |
| 125568551 | 12556855 | Rash | |
| 125568551 | 12556855 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125568551 | 12556855 | 1 | 201510 | 201511 | 0 | |
| 125568551 | 12556855 | 2 | 201601 | 20160407 | 0 |